Dier Medical USA and its Overseas R&D Center Have Officially Been Established.

Release date:

2011-06-16

On June 16, 2011, Zhuhai Dier Bioengineering Co., Ltd. registered DLBIOTECHUSAINC in the United States and officially commenced operations effective immediately, marking the establishment of Dier Medical’s first overseas subsidiary and its overseas R&D center. The founding of Dier USA and its R&D center aims to swiftly and efficiently assimilate cutting-edge, world‑class technological innovations, continuously strengthening Dier Medical’s core competitiveness in microbial medical technology. The U.S. entity assumes a strategic role in executing Dier Medical’s R&D roadmap for the next three to five years, collaborating seamlessly with Dier Medical’s China R&D Center on a round‑the‑clock, continuous basis.



 2011 year 6 month 16 day  , Zhuhai Deer Bioengineering Co., Ltd. was registered and established in the United States.  DL BIOTECH  USA INC ，

 And effective immediately, it has officially commenced operations, marking Deere Medical’s first overseas subsidiary and its first overseas R&D center.  It was born. 
  The establishment of Deere U.S. and its R&D center aims to swiftly and efficiently bring forth cutting-edge, world-class technologies that represent the international forefront. 
 Creation  New acquisitions are continuously strengthening Dier’s core competitive edge in microbiological medical technology, with the U.S. company poised to shape Dier’s future.  3-5  Year of Research 
 The strategic mission of the development plan, adopted by Deere Medical China R&D Center 24 A round-the-clock collaborative R&D model is jointly employed to develop products. 
 We will efficiently develop a series of high-quality, high-tech, high-precision microbial testing and analytical instruments that represent the international cutting edge. 
 Together with in vitro diagnostic reagents, it is provided to medical institutions at all levels across China and serves the public and society.

2026-07-03

BISC2026 | Dier Bio’s Automated Antimicrobial Susceptibility Testing Empowers Precise Prevention and Control of Bacterial and Fungal Resistance

2026-06-02

Uniting Forces in Europe, Illuminating the Future | Dier Biotech Participates in ESCMID 2026

2026-04-22

Grateful for the encounter, trusting in our shared journey | Deer Bio’s CMEF concluded successfully—every mutual effort is worth cherishing.

2026-04-15

Towards Innovation and Excellence: Precision Diagnostics | Dier Bio Showcases Its Core Products at the 2026 Medical Equipment Expo

2026-04-01

Gathering Momentum on Egret Island, Celebrating Artisanal Excellence | Dier Biotech Successfully Concludes CACLP 2026

2026-03-23

Share to

Return to list

Dier Bio: Making infectious disease diagnosis faster and more accurate.

Are you ready to embark on a journey into the world of microbes?

Deer Bio WeChat Official Account

Tel: 0756-3391888

Address: No. 59, Dingwan Tenth Road, Jinwan District, Zhuhai City
Email: market@medicaldl.com
dl@medicaldl.com (for export business)
National After-Sales Customer Service Hotline: 400-9313-018
International Customer Service Hotline: +86 756 6292044

Consult Now

SEO tags

Business license

market@medicaldl.com：market@medicaldl.com

0756-3391888：0756-3391888

Sorry, there is currently no content in this section.

You can view other sections.

Sorry, there is currently no content in the current column

You can check other sections

Business license

Business License